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Objectives: The Delta Study was undertaken to improve the diagnosis of mood 
disorders in individuals presenting with low mood. The current study aimed to 
estimate the prevalence and explore the characteristics of mood disorders in 
participants	of	the	Delta	Study,	and	discuss	their	implications	for	clinical	practice.
Methods: Individuals	with	low	mood	(Patients	Health	Questionnaire-	9	score	≥5)	and	
either	no	previous	mood	disorder	diagnosis	 (baseline	 low	mood	group,	n =	429),	a	
recent	(≤5	years)	clinical	diagnosis	of	MDD	(baseline	MDD	group,	n =	441)	or	a	previous	
clinical	diagnosis	of	BD	(established	BD	group,	n =	54),	were	recruited	online.	Self-	
reported demographic and clinical data were collected through an extensive online 
mental health questionnaire and mood disorder diagnoses were determined with the 
World	Health	Organization	Composite	International	Diagnostic	Interview	(CIDI).
Results: The prevalence of BD and MDD in the baseline low mood group was 24% and 
36%,	respectively.	The	prevalence	of	BD	among	individuals	with	a	recent	diagnosis	of	








health triage in primary care.
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1  | INTRODUC TION
Major	depressive	disorder	(MDD)	and	bipolar	disorder	(BD)	are	com-

















prior treatment response. The World Health Organization World 
Mental Health Composite International Diagnostic Interview (CIDI 
(Kessler	&	Üstün,	2004))	can	be	a	useful	tool	for	the	assessment	and	
differential diagnosis of MDD and BD. It also captures subthreshold 
forms	of	elevated	mood,	including	subthreshold	BD	and	MDD	with	
subthreshold	BD,	with	 individuals	 presenting	with	 fewer	 and/or	 a	
shorter	duration	of	(hypo)manic	symptoms.
Both MDD and BD typically start early in life and are associated 
with	 severe	 functional	 impairments,	 high	morbidity	 and	mortality,	
including	premature	death	due	to	suicide	(Bourne	et	al.,	2013;	Passos	
et	al.,	2016;	Ösby	et	al.,	2016).	The	economic	burden	of	MDD	and	
BD	 is	also	substantial;	 in	England,	direct	and	 indirect	annual	costs	
are	estimated	at	£7.46	billion	(US	$9.85	billion)	for	MDD	and	£5.25	
billion	 (US	$6.93	billion)	 for	BD	 (McCrone	et	al.,	2008).	 In	spite	of	
their	prevalence	and	negative	prognosis,	the	recognition	and	diagno-
sis	of	these	conditions	presents	a	significant	challenge,	particularly	
in	 the	primary	care	setting.	For	 instance,	 research	has	shown	that	
general	 practitioners	 (GPs)	 initially	misdiagnose	 50%	 of	MDD	 pa-
tients	(Mitchell	et	al.,	2009).	Short	consultation	times	coupled	with	
the	 difficulties	 associated	 with	 diagnosing	 MDD,	 where	 any	 two	
individuals	may	have	no	symptoms	in	common	(Olbert	et	al.,	2014;	
Fried	et	al.,	2014),	means	 that	many	are	not	 receiving	 the	support	
they	need.	This	is	a	particular	issue,	given	that	the	vast	majority	of	




10	 years	 before	 receiving	 a	 correct	 diagnosis	 (Bauer	 et	 al.,	 2018;	
Patel	et	al.,	2015).	This	is	due,	in	part,	to	the	fact	that	the	majority	of	
individuals with BD seek help when they are experiencing depres-
sive	symptoms	as	opposed	to	when	they	are	in	a	(hypo)manic	state.	
Furthermore,	in	most	instances,	depressive	episodes	precede	a	first	
(hypo)manic	 episode,	 and	 awareness	 of	 one's	 (hypo)manic	 symp-
toms	is	relatively	 low	(Regeer	et	al.,	2015).	This	poses	a	significant	
problem	for	the	diagnosis,	treatment,	and	management	of	BD,	with	
these individuals likely to be treated with antidepressant monother-




Taken	 together,	 the	 careful	 evaluation	 and	management	 of	 all 
patients presenting with depressive symptoms is warranted. Even 
in	the	absence	of	a	(hypo)manic	episode,	individuals	diagnosed	with	
MDD should be closely monitored and managed. This is because 
symptoms	 of	 MDD	 are	 frequently	 the	 initial	 presentation	 of	 BD,	
with	factors	including	greater	depression	severity,	recurrent	MDD,	
and psychotic symptoms associated with a later BD diagnosis (Holma 
et	al.,	2008).	Other,	patient-	level	 risk	 factors	 that	are	 indicative	of	
the disorder comprise an earlier age of onset of depressive symp-
toms,	being	white,	living	alone,	not	being	married,	and	being	unem-
ployed	 (Hirschfeld	 et	 al.,	 2005).	While	 the	 collection	 of	 extensive	
symptom-	and	patient-	level	data	may	prove	difficult	in	the	primary	








to	 develop	 and	 validate	 diagnostic	 algorithms,	 based	on	 an	 online	
mental	health	questionnaire	and	blood	biomarker	data,	that	would	
reduce the misdiagnosis of BD as MDD as well as achieve a more 
accurate and timely diagnosis of MDD in those presenting with de-
pressive symptoms. We adapted voluntary response sampling and 
online advertising to meet study recruitment targets estimated from 
published	reports	 (Benazzi,	1997;	Hantouche	et	al.,	1998;	Zuithoff	
et	al.,	2010;	Sung	et	al.,	2013).	The	present	study	examined	the	re-
sulting prevalence and characteristics of mood disorders in the Delta 
Study	population,	determined	using	the	CIDI,	and	their	implications	
for clinical practice.
2  | PARTICIPANTS AND METHODS
2.1 | Study design and participants
Data shown in the present work were collected as part of the 
Delta	 Study	 (International	 Registered	 Report	 Identifier	 RR1-	
10.2196/18453),	 an	 investigator-	led	 study	 conducted	 by	 the	
Cambridge	 Centre	 for	 Neuropsychiatric	 Research	 (CCNR)	 at	 the	
University	 of	 Cambridge,	 which	 aimed	 to	 improve	mood	 disorder	
diagnoses in participants presenting with depressive symptoms 
(Olmert	 et	 al.,	 2020).	 The	 primary	 objective	 of	 the	 Delta	 Study	
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was to identify BD patients among patients diagnosed as having 
MDD. The secondary objective of the Delta Study was to identify 
patients with MDD among undiagnosed low mood individuals. To 
this	end,	three	patient	groups	were	recruited.	The	first	group	com-
prised patients with current depressive symptoms who had recently 
(≤5	years)	(Ghaemi	et	al.,	1999;	Morselli	et	al.,	2003)	been	diagnosed	
with	MDD,	 the	 second	group	 comprised	participants	with	 current	
depressive	symptoms	and	no	lifetime	mood	disorder	diagnosis,	and	




ducted in compliance with the Declaration of Helsinki (World Medical 
Association,	2013),	Good	Clinical	Practice,	and	 ISO	14155:2011.	A	
detailed research protocol for the Delta Study has been published 
previously	 (Olmert	et	al.,	2020).	Participants	were	recruited	online	
through	email,	via	the	CCNR	website,	and	Facebook.	 Inclusion	cri-
teria	 for	 the	 study	were	as	 follows:	 age	18	 to	45	years,	 residency	
in	 the	United	 Kingdom,	 at	 least	mild	 depressive	 symptoms	 in	 the	
past	 two	 weeks	 (Patient	 Health	 Questionnaire	 (PHQ)-	9	 (Kroenke	
et	al.,	2001)	total	score	≥5),	not	pregnant	or	breastfeeding,	and	not	
currently	 suicidal.	All	participants	 read	 the	participant	 information	
sheet and digitally provided informed consent for participation in 
the	study.	Recruitment	started	on	April	27,	2018	and	was	completed	
on	September	28,	2018.	The	current	report	was	prepared	in	compli-
ance with the Strengthening the Reporting of Observational Studies 
in	Epidemiology	(STROBE)	(Elm	et	al.,	2007)	guidelines.
2.2 | Online mental health questionnaire
Upon	 enrolment,	 participants	were	 asked	 to	 complete	 a	 purpose-	
built online mental health questionnaire available through the Delta 
Study website. The online mental health questionnaire was devel-
oped in collaboration with experienced psychiatrists and a service 
user	advisory	group,	and	was	based	on	existing	structured	diagnos-
tic interviews as well as a range of mental health screening ques-
tionnaires. It consisted of 635 distinct questions divided into six 
modules:	i)	demographic	information;	ii)	manic	and	hypomanic	symp-
toms;	 iii)	depressive	symptoms;	 iv)	personality	traits;	v)	psychiatric	
history	 and	 vi)	 other	 psychiatric	 conditions.	 Participant	 wellbeing	
in	the	past	two	weeks	was	assessed	using	the	Warwick-	Edinburgh	
F I G U R E  1   Delta Study flow diagram. Figure shows the number of individuals who completed each step of the study and reasons for 
attrition.	BD,	bipolar	disorder;	DBS,	dried	blood	spot;	MDD,	major	depressive	disorder;	WHO	WMH-	CIDI,	World	Health	Organization	World	
Mental Health Composite International Diagnostic Interview
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Mental	Wellbeing	Scale	(WEMWBS)	(Tennant	et	al.,	2007).	The	on-
line mental health questionnaire was adaptive to answers given by 
participants,	 so	 that	 only	 relevant	 questions	were	 asked,	 and	 the	
maximum possible number of questions asked to an individual was 
382	(284	on	average).	Data	collected	from	the	online	mental	health	
questionnaire were used to identify participants qualifying for the 
study's	 primary	 and	 secondary	 objectives	 following	 a	 pre-	defined	
study	 protocol.	 Among	 the	 identified	 participants,	 those	 eligible	
for	the	diagnostic	interview	had	to:	i)	consent	to	providing	a	blood	
sample	(self-	collected	dried	blood	spots)	and	completing	a	telephone	
diagnostic	 interview;	 ii)	be	free	from	blood-	borne	 illnesses;	and	 iii)	
have no previous diagnosis of schizophrenia.
2.3 | Diagnostic interview
Participants who successfully completed the online mental health 
questionnaire	and	returned	a	dried	blood	spot	(DBS)	sample	were	
invited	to	complete	the	CIDI,	version	3.0	 (Kessler	&	Üstün,	2004)	
via telephone. The CIDI is a modular diagnostic tool which is 
widely	 used	 in	 epidemiological	 studies	 on	mental	 health	 (Kessler	
et	al.,	2005).	It	shows	good	concordance	with	structured	diagnostic	
interviews	conducted	by	clinicians,	such	as	the	Structured	Clinical	










MDD	with	 subthreshold	BD,	and	none,	 referred	 to	as	 ‘low	mood’	
hereafter.	We	adopted	voluntary	response	sampling,	whereby	the	
CIDI	 interviews	 continued	 until	 pre-	specified	 study	 recruitment	
targets were met.
2.4 | Statistical analysis
Power calculations showed that a minimum of 300 participants 
with a recent diagnosis of MDD by a medical professional and 300 
symptomatic participants with no baseline diagnosis of mood disorder 
were	required.	Additionally,	we	aimed	to	recruit	40	participants	with	
a previous diagnosis of BD made by a medical professional to provide 






variables	 and	 pairwise	 chi-	squared	 tests	 (R	 package	 ‘rcompanion’	
(Mangiafico,	 2020))	 for	 categorical	 variables,	 with	 Bonferroni	
correction for multiple comparisons. Figures were prepared in R and 
Inkscape version 1.0.
3  | RESULTS
The study flow diagram is shown in Figure 1. To achieve study 
recruitment	 targets,	 5,422	 symptomatic	 individuals	were	 enrolled,	
of	which	3,232	 completed	 the	online	mental	 health	questionnaire	
and 924 completed the CIDI diagnostic interview. The average time 
interval between starting the online mental health questionnaire and 
completing the CIDI interview was 14 days. The dataset comprised of 
three groups: low mood individuals with no previous mood disorder 
diagnosis (N =	429);	participants	with	a	recent	(≤5	years)	diagnosis	
of MDD and no previous diagnosis of BD (N =	441);	and	participants	
with a previously established diagnosis of BD (N =	 54;	 Figure	 1).	
Of the 429 symptomatic participants with no previous diagnosis of 
mood	disorder,	the	two	largest	groups	comprised	154	participants	
(36%)	 with	 newly	 diagnosed	 MDD,	 including	 20	 individuals	 (5%)	
with	 concurrent	 subthreshold	 BD,	 and	 141	 (33%)	 low	 mood	
individuals	 (i.e.,	 no	 mood	 disorder	 diagnosis	 by	 CIDI)	 (Figure	 2a).	
The remaining diagnoses in the baseline low mood group included 
F I G U R E  2  World	Health	Organization	Composite	International	Diagnostic	Interview	(CIDI)	outcomes	across	the	Delta	Study	populations.	
The	pie	charts	show	the	distribution	of	CIDI	diagnoses	in	participants	with	(a)	baseline	depressive	symptoms	and	no	previous	mood	disorder	
diagnosis (N =	429),	(b)	baseline	MDD	diagnosis	and	no	previous	BD	diagnosis	(N =	441),	and	(c)	baseline	BD	diagnosis	(N =	54).	BD,	bipolar	
disorder;	MDD,	major	depressive	disorder
(a) (b) (c)
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of participants (N =	 242;	 55%),	 of	 which	 26	 (6%)	 had	 concurrent	
subthreshold	 BD	 (Figure	 2b).	 Furthermore,	 135	 participants	 from	
the	baseline	MDD	group	(31%)	were	diagnosed	with	BD	by	the	CIDI,	
including	80	participants	(18%)	with	BDI	and	55	participants	(12%)	
with BDII. The remaining diagnoses in the baseline MDD group 
included	38	participants	(9%)	with	subthreshold	BD	and	26	(6%)	low	








with BDI were also more likely to have experienced childhood trauma 





with BDII were younger when they experienced their first depres-
sive	 episode,	 and	 individuals	with	 BDI	 and	MDD	 reported	 having	
experienced a higher number of low mood episodes relative to the 
low	mood	group.	As	expected,	individuals	with	BDI	reported	having	
experienced a higher number of episodes characterized by elevated 
mood	in	comparison	to	the	MDD	and	low	mood	groups,	and	both	the	





differences were observed in participants with no previous mood 
disorder diagnosis.
Of	those	who	had	been	previously	diagnosed	with	MDD,	partic-
ipants with newly diagnosed BDI were more likely to smoke relative 
to	the	MDD	and	subthreshold	BD	groups.	Furthermore,	individuals	
with BDI had lower levels of education in comparison to those with 
MDD,	and	rated	their	mental	health	as	being	worse	relative	to	the	
low mood group. The MDD group was more likely to have been pre-
viously	 diagnosed	with	MDD	by	 a	GP,	while	BDI	 individuals	were	






als with BD diagnosed as MDD by a psychiatrist experienced manic 
symptoms	after	being	diagnosed	with	MDD	(Table	2).	Participants	
with BD were younger when they experienced their first low mood 
episode	relative	to	the	low	mood	group.	In	addition,	individuals	with	
BD and MDD with subthreshold BD reported having experienced 
more episodes characterized by elevated mood in comparison to 
MDD	and	low	mood	groups.	Similarly,	those	with	subthreshold	BD	
reported having experienced more elevated mood episodes relative 
to the MDD group. Individuals with BDI reported higher depression 
severity	in	comparison	to	the	MDD	and	low	mood	groups.	Similarly,	
individuals with BDII scored higher in depression severity relative 
to	the	low	mood	group.	Furthermore,	individuals	with	BDI	reported	
poorer wellbeing in comparison to those with low mood. There were 




of BD. The majority of participants with an existing diagnosis of BD 
reported	a	previous	diagnosis	of	MDD	(81%,	44/54)	and	had	been	
treated	with	antidepressant	medication	(89%,	48/54).	As	expected,	
MDD	 diagnoses	 in	 this	 group	 were	 made	 mostly	 by	 a	 GP	 (52%,	
23/44),	while	the	BD	diagnoses	were	made	primarily	by	a	psychia-
trist	 (87%,	47/54).	Approximately	half	 (47%,	18/38)	of	participants	
with	 established	 BD	 diagnosed	 initially	 as	 MDD,	 for	 whom	 data	





7.3 ± 6.6 years.
4  | DISCUSSION
The aim of the present study was to explore the prevalence and 
characteristics of mood disorders in the Delta Study population. 
Overall,	 the	 present	 findings	 support	 the	 notion	 that	 all	 individu-





and	patient	 stratification,	 and	 allowing	 for	personalized	 treatment	
plans and strategies. Of the symptomatic individuals with no previ-
ous	diagnosis	of	mood	disorder,	 the	prevalence	rates	of	MDD	and	
BD	were	36%	and	24%,	respectively,	while	33%	did	not	meet	criteria	
for either disorder. Individuals who were newly diagnosed with BDI 
were more likely to have suffered childhood trauma relative to the 
low	mood	group.	Although	the	online	mental	health	questionnaire	
employed in the Delta Study did not capture different forms of child-
hood	trauma	(e.g.,	emotional,	physical,	or	sexual	abuse),	research	has	
demonstrated that emotional abuse may be particularly associated 
with	BD	(Janiri	et	al.,	2015;	Etain	et	al.,	2010).	Regarding	depressive	
states,	those	with	BDII	were	significantly	younger	when	they	expe-
rienced their first low mood episode relative to the MDD and low 
mood	groups,	consistent	with	an	earlier	age	at	onset	of	BD	compared	
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to	 MDD	 (Tondo	 et	 al.,	 2010).	 Interestingly,	 individuals	 diagnosed	








number of elevated mood episodes was higher in BDII and sub-
threshold BD in comparison to those with low mood. These findings 
emphasize	the	importance	of	assessing	for	(hypo)manic	symptoms	in	
patients	presenting	with	low	mood,	particularly	in	light	of	the	largely	
indistinguishable differences in depressive episodes between BD 
and MDD.
Regarding participants who had been previously diagnosed with 
MDD,	 the	 findings	 from	 the	 current	 study	 revealed	 that	31%	met	
the criteria for BD according to the CIDI. The prevalence of BD pre-
viously diagnosed as MDD in the current study was consistent with 
figures	 found	 in	 the	 literature,	which	vary	between	10%	and	50%	
(Cassano	et	al.,	1992;	Ghaemi	et	al.,	2002;	Benazzi,	1997;	Hirschfeld	
et	 al.,	 2003;	 Shen	 et	 al.,	 2018).	 This	 variation	 could	 be	 attributed	
to	differences	in	recruitment	and	sampling	procedures.	Notably,	an	
exploration	 of	 symptom-	 and	 patient-	level	 data	 revealed	 that	BDI	
individuals with a previous diagnosis of MDD were less educated 




sion severity between BD and MDD in those with no previous mood 
disorder	 diagnosis,	 participants	 with	 BDI	 previously	 diagnosed	 as	
MDD	scored	higher	on	the	PHQ-	9	relative	to	MDD	and	low	mood	
individuals,	 potentially	 reflecting	 the	 effects	 of	 receiving	 ineffec-
tive	 treatment	 (e.g.,	 antidepressant	monotherapy)	 and	 the	 lack	 of	
support	due	 to	 incorrect	diagnosis.	Similarly,	 individuals	with	BDII	
previously diagnosed as MDD exhibited elevated depression se-
verity relative to the low mood group. These findings are largely in 
line with studies revealing a direct association between depression 
severity	 and	BD	 (Strober	&	Carlson,	1982;	Holma	et	 al.,	 2008).	 In	
accordance	with	previous	research	(Hirschfeld	et	al.,	2005)	and,	 in	
part,	with	the	results	from	the	baseline	low	mood	group,	individuals	
with BD reported being younger when they experienced their first 
low	mood	episode	relative	to	the	 low	mood	group,	and	individuals	
with BDI reported poorer quality of mental health and wellbeing. 
Furthermore,	in	line	with	the	findings	in	individuals	with	no	previous	
mood	disorder	diagnosis,	individuals	with	BD	reported	having	expe-
rienced more episodes characterized by elevated mood relative to 
the	MDD	and	low	mood	groups.	Importantly,	70%	of	BDI	individuals	
who	had	been	diagnosed	with	MDD	were	assessed	by	a	GP,	with	the	
majority of these reporting having experienced episodes of elevated 
mood prior to being assessed. These findings stress the importance 
of	asking	about	(hypo)manic	symptoms	in	the	primary	care	setting,	
with the presence of elevated mood warranting further evaluation 
by	 a	 psychiatrist,	 as	 recommended	 by	 the	 National	 Institute	 for	
Health	 and	Care	Excellence	 (NICE)	 (National	Collaborating	Centre	
for	Mental	Health	(UK),	2014).
Importantly,	 the	current	 research	has	a	number	of	 limitations.	
Firstly,	 due	 to	 the	 cross-	sectional	 nature	of	 the	 study	design,	we	








after MDD diagnosis NA
GP 11 8 4
Psychiatrist 6 9 1
Other medical professional 0 2 1




TA B L E  3   Relative timing of MDD 
diagnosis	and	first	(hypo)manic	symptoms	
in established BD patients initially 





after MDD diagnosis NA
GP 50 36 10
Psychiatrist 16 19 4
Other medical professional 0 0 0




TA B L E  2   Relative timing of MDD 
diagnosis	and	first	(hypo)manic	symptoms	
in BD patients previously diagnosed with 
MDD (N =	135)
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CIDI	was	89%	 sensitive	 in	 detecting	previously	 diagnosed	partic-
ipants	with	BD,	hence	 introducing	diagnostic	 uncertainty.	 Finally,	
the recruitment material targeted individuals who were concerned 
about	their	mood	disorder	diagnosis,	particularly	those	with	a	high	
risk	of	BD.	As	such,	there	is	likely	to	be	a	recruitment	bias	and	the	
findings from the current study may not generalize to the broader 
population or to those with more severe forms of psychopathology. 
Despite	 these	 limitations,	 this	 is	 the	 first	diagnostic	 study,	 to	our	
knowledge,	 to	 extensively	 evaluate	 a	 large	 online	 cohort	 of	 indi-
viduals suffering from mood disorders or low mood. The current 
findings have important clinical implications and indicate an urgent 
need	 for	 innovative,	 accessible,	 time-	 and	 cost-	effective	 alterna-
tives	to	conventional,	interview-	based	diagnostic	methods.	Further	
research is necessary in order to explore the potential of using an 














offer excellent discriminatory performance when distinguishing 
between	BD	and	MDD	(Tomasik	et	al.,	2021).	While	time	 is	a	pre-
mium	 in	 primary	 care	 settings,	with	 50%	of	 the	 global	 population	
spending five minutes or less per visit with their primary care physi-
cian	 (Irving	 et	 al.,	 2017),	 a	 highly	 scalable,	 low-	cost	 online	mental	
health questionnaire has the potential to facilitate the identifica-
tion	of	BD	and	MDD	 in	 those	presenting	with	 low	mood.	Second,	
in	 light	 of	 the	 potential	 for	 the	misdiagnosis	 of	 BD,	 all	 individuals	
diagnosed	 with	MDD	 should	 be	 closely	 monitored	 and	 managed,	
with	antidepressant-	induced	 (hypo)mania	and	non-	response	to	an-
tidepressant medication warranting specialized evaluation by a psy-
chiatrist to rule out a BD diagnosis.
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